Literature DB >> 21995974

Three principles to define the success of a diagnostic study could be identified.

Werner Vach1, Oke Gerke, Poul Flemming Høilund-Carlsen.   

Abstract

OBJECTIVE: Diagnostic studies are typically studies with two endpoints, sensitivity and specificity. To define the success of a diagnostic study, results for these two endpoints have to be combined in an appropriate manner. STUDY DESIGN AND
SETTING: Identification of criteria to define the success of a diagnostic study on a single binary test and investigation of common statistical approaches in relation to these criteria.
RESULTS: Three criteria for defining the overall success of a diagnostic study could be identified: a strong criterion, a liberal criterion, and a weak criterion. The strong criterion can be implemented by comparing the lower bounds of the confidence intervals for sensitivity and specificity with prespecified target values, as is typically done in many diagnostic studies. The liberal criterion allows a clinically meaningful compensation between sensitivity and specificity and can be implemented in different ways. If the liberal criterion is applied instead of the strong criterion, this can lead to a substantial reduction in the sample size required for a diagnostic study. The weak criterion is not very adequate for defining the success of a diagnostic study.
CONCLUSION: When planning and analyzing diagnostic studies, the criterion to define the success of the study should be clearly prespecified. The results of the statistical approach taken should be interpreted in accordance with this criterion. This ensures coherence of results and prevents unnecessarily large sample sizes. The liberal criterion should be paid more attention to in the future.
Copyright © 2012 Elsevier Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 21995974     DOI: 10.1016/j.jclinepi.2011.07.004

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  6 in total

1.  Demonstrating the benefits of clinical nuclear imaging: is it time to add economic analysis?

Authors:  Poul F Høilund-Carlsen; Oke Gerke; Werner Vach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09       Impact factor: 9.236

2.  FDG PET/CT in cancer: comparison of actual use with literature-based recommendations.

Authors:  Henrik Petersen; Paw Christian Holdgaard; Poul Henning Madsen; Lene Meldgaard Knudsen; Dorte Gad; Anders Eggert Gravergaard; Max Rohde; Christian Godballe; Bodil Elisabeth Engelmann; Karsten Bech; Dorte Teilmann-Jørgensen; Ole Mogensen; Jens Karstoft; Jørgen Johansen; Janne Buck Christensen; Allan Johansen; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-30       Impact factor: 9.236

3.  STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

Authors:  Jérémie F Cohen; Daniël A Korevaar; Douglas G Altman; David E Bruns; Constantine A Gatsonis; Lotty Hooft; Les Irwig; Deborah Levine; Johannes B Reitsma; Henrica C W de Vet; Patrick M M Bossuyt
Journal:  BMJ Open       Date:  2016-11-14       Impact factor: 2.692

4.  Bayesian sample size determination for diagnostic accuracy studies.

Authors:  Kevin J Wilson; S Faye Williamson; A Joy Allen; Cameron J Williams; Thomas P Hellyer; B Clare Lendrem
Journal:  Stat Med       Date:  2022-04-10       Impact factor: 2.497

5.  Relationship of the p22phox (CYBA) gene polymorphism C242T with risk of coronary artery disease: a meta-analysis.

Authors:  Zhijun Wu; Yuqing Lou; Wei Jin; Yan Liu; Lin Lu; Qiujing Chen; Yucai Xie; Guoping Lu
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

6.  Heterogeneous effect of two selectin gene polymorphisms on coronary artery disease risk: a meta-analysis.

Authors:  Zhijun Wu; Yuqing Lou; Lin Lu; Yan Liu; Qiujing Chen; Xin Chen; Wei Jin
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.